SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs expands anti-diabetic capacity

24 Oct 2019 Evaluate

Aarti Drugs has recently expanded its anti-diabetic capacity and currently scaling up its production quantities for the same. Further, brown field CAPEX would be done in the current financial year to expand few capacities in anti-inflammatory therapeutic category.

Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.

Aarti Drugs Share Price

397.95 10.40 (2.68%)
09-Jul-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1946.40
Dr. Reddys Labs. 1299.00
Cipla 1447.40
Zydus Lifesciences 1169.95
Lupin 2510.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: